SmPC - Paclitaxel 6mg/ml Concentrate for solution for infusion: Change history
View Summary of Product Characteristics (SmPC - Paclitaxel 6mg/ml Concentrate for solution for infusion)
Last updated on this site: 30 Dec 2025
Description of update: To update sections 4.4, 4.6, 4.8 of the SmPC and sections 2, 4 of the leaflet information in line with the information of reference product (Taxol 6 mg/ml, concentrate for solution for infusion; MAH: Cheplapharm Arzneimittel GmbH; procedure number: IT/H/0693/001).
Date of approval: 23/12/2025
SmPC sections updated: 4.4, 4.5, 4.6, 4.8 and 10
Last updated on this site: 30 Dec 2025
Description of update: To update sections 4.4, 4.6, 4.8 of the SmPC and sections 2, 4 of the leaflet information in line with the information of reference product (Taxol 6 mg/ml, concentrate for solution for infusion; MAH: Cheplapharm Arzneimittel GmbH; procedure number: IT/H/0693/001).
Date of approval: 23/12/2025
SmPC sections updated: 4.4, 4.5, 4.6, 4.8 and 10
-
Changes: (Updated: 30 Dec 2025)
Description of update: To update sections 4.4, 4.6, 4.8 of the SmPC and sections 2, 4 of the leaflet information in line with the information of reference product (Taxol 6 mg/ml, concentrate for solution for infusion; MAH: Cheplapharm Arzneimittel GmbH; procedure number: IT/H/0693/001).
Date of approval: 23/12/2025
SmPC sections updated: 4.4, 4.5, 4.6, 4.8 and 10
-
Changes: (Updated: 21 Sep 2022)
Initial upload